![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/MUKKA.png)
Share the post "Mukka Proteins ‘s Q3 2024-25 Latest News: Profit Rises by 122.04% YoY"
Highlights
🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance. 🔹 Sales over the Year and quarter: The company’s sales declined by -41.36 % over the year, substantial increase in net sales/revenue by 103.19 %. 🔹 Income over the Year and quarter: There has been decline in other income over the past year which is -6.2 %, Marginal increase in other income during this quarter, up by 84.68%. 🔹 Profit over the Year and quarter: Significant improvement in profitability for Mukka Proteins Limited. Notable increase of 122.04 % in net profit Year to Year, Mukka Proteins Limited’s profitability increased by 1720.65 % in this quarter. 🔹 EPS over the Year and quarter: EPS increased by 83.33 % Year to Year. EPS increased by 1157.14 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 516.985 Cr | Rs. 149.194 Cr | Rs. 303.152 Cr | + 103.19 % | -41.36 % |
| Expenses | Rs. 498.11 Cr | Rs. 139.63 Cr | Rs. 261.8 Cr | + 87.5 % | -47.44 % |
| Operating Profit | Rs. 18.88 Cr | Rs. 9.56 Cr | Rs. 41.35 Cr | + 332.53 % | + 119.01 % |
| OPM % | 3.65 % | 6.41 % | 13.64 % | + 7.23 % | + 9.99 % |
| Other Income | Rs. 6.182 Cr | Rs. 3.14 Cr | Rs. 5.799 Cr | + 84.68 % | -6.2 % |
| Interest | Rs. 6.15 Cr | Rs. 8.72 Cr | Rs. 10.91 Cr | + 25.11 % | + 77.4 % |
| Depreciation | Rs. 3.18 Cr | Rs. 3.76 Cr | Rs. 3.8 Cr | + 1.06 % | + 19.5 % |
| Profit before tax | Rs. 15.73 Cr | Rs. 0.22 Cr | Rs. 32.44 Cr | + 14645.45 % | + 106.23 % |
| Tax % | 34.32 % | 187.11 % | 19.02 % | -168.09 % | -15.3 % |
| Net Profit | Rs. 12.07 Cr | Rs. 1.47 Cr | Rs. 26.8 Cr | + 1723.13 % | + 122.04 % |
| EPS in Rs | Rs. 0.48 | Rs. 0.07 | Rs. 0.88 | + 1157.14 % | + 83.33 % |
Today, we’re looking at Mukka Proteins Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a significant year-over-year sales decline of -41.36 %. However, it did see a marginal increase of 103.19 % from the previous quarter. Expenses ticked up slightly by 87.5 % quarter-on-quarter, aligning with the annual decline of -47.44 %. Operating profit, while up 119.01 % compared to last year, faced a quarter-on-quarter increase of 332.53 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 9.99 %, but an expansion of 7.23 % sequentially. Other income rose by 84.68 % compared to the last quarter, despite an annual decline of -6.2 %. Interest expenses surged remarkably by 25.11 % from the previous quarter, yet the year-over-year increase remains at a moderate 77.4 %. Depreciation costs climbed by 1.06 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 19.5 %. Profit before tax grew annually by 106.23 % but saw an increase from the preceding quarter by 14645.45 %.
Tax expenses as a percentage of profits decreased slightly by -15.3 % compared to last year, with a more notable quarter-on-quarter decrease of -168.09 %. Net profit rose by 122.04 % year-on-year but experienced a 1723.13 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 83.33 % but a quarterly rise of 1157.14 %. In summary, Mukka Proteins Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 516.985 Cr | Rs. 149.194 Cr | Rs. 303.152 Cr | + 103.19 % | -41.36 % |
| Expenses | Rs. 498.11 Cr | Rs. 139.63 Cr | Rs. 261.8 Cr | + 87.5 % | -47.44 % |
| Operating Profit | Rs. 18.88 Cr | Rs. 9.56 Cr | Rs. 41.35 Cr | + 332.53 % | + 119.01 % |
| Net Profit | Rs. 12.07 Cr | Rs. 1.47 Cr | Rs. 26.8 Cr | + 1723.13 % | + 122.04 % |
| EPS in Rs | Rs. 0.48 | Rs. 0.07 | Rs. 0.88 | + 1157.14 % | + 83.33 % |
In reviewing Mukka Proteins Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -41.36 % year-on-year, however, there was a minor increase of 103.19 % from the previous quarter. Expenses decreased by -47.44 % compared to the previous year, with a 87.5 % increase quarter-on-quarter. Operating Profit surged by 119.01 % annually, and saw a 332.53 % increase from the last quarter.
Net Profit showed yearly increase of 122.04 %, and experienced a 1723.13 % increase from the previous quarter. Earnings Per Share (EPS) rose by 83.33 % annually, however rose by 1157.14 % compared to the last quarter. In essence, while Mukka Proteins Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/CHOKSILA.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/POOJAENT.png)